Inhibition of DNL by skeletal muscle-specific FASN deletion improves systemic insulin sensitivity without altering adiposity, but decreases muscle strength [29], suggesting that DNL also plays important roles in skeletal muscle, especially in states of insulin resistance. The gene discussed is INS; the disease is Insulin resistance.